Quanterix Corporation's (QTRX) CEO Kevin Hrusovsky on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/09/20
Kevin Hrusovsky to Speak at Precision Medicine Leaders Summit's Precision Oncology ConferenceBusiness Wire • 10/28/20
Quanterix Enters into a License Agreement that Grants Abbott Access to Portfolio of Bead-Based Technology Patents for Use in In Vitro DiagnosticsBusiness Wire • 10/05/20
Quanterix: The Illumina Of Proteomics - Life Science Tools Play At A Reasonable ValuationSeeking Alpha • 09/15/20
Quanterix Announces Closing of Public Offering Including Exercise in Full of Underwriters’ Option to Purchase Additional SharesBusiness Wire • 08/11/20
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/09/20
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/09/20
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/10/20
Quanterix Corp (QTRX) CEO Kevin Hrusovsky on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/10/19
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/10/19
Quanterix Corporation (QTRX) CEO Kevin Hrusovsky on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/11/19